Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904)
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Boston Children's Hospital
Centre Henri Becquerel
Thomas Jefferson University
Masonic Cancer Center, University of Minnesota
Beijing Suncadia Pharmaceuticals Co., Ltd
Thomas Jefferson University
Fred Hutchinson Cancer Center
AstraZeneca
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Radboud University Medical Center
Radboud University Medical Center
Ottawa Hospital Research Institute
Memorial Sloan Kettering Cancer Center
AstraZeneca
Virginia Commonwealth University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Celgene
Centre Hospitalier Universitaire de Saint Etienne
M.D. Anderson Cancer Center
The First Affiliated Hospital with Nanjing Medical University
Thomas Jefferson University
Merck Sharp & Dohme LLC
Dana-Farber Cancer Institute
University of Alabama at Birmingham
National Cancer Institute (NCI)
Kyntra Bio
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Masonic Cancer Center, University of Minnesota
National Cancer Center, Korea
University of Colorado, Denver
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Reprixys Pharmaceutical Corporation
Fred Hutchinson Cancer Center
AstraZeneca
Boston Children's Hospital
M.D. Anderson Cancer Center
University of Maryland, Baltimore
Roswell Park Cancer Institute
Novartis
University of Arizona
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Stanford University
Pfizer
Nohla Therapeutics, Inc.
Massachusetts General Hospital
National Heart, Lung, and Blood Institute (NHLBI)